Rhenovia Pharma
Latest round
- Series C
Last raised
- Jun 2010
Total raised
- $0.4M
Investors
- 2
About Rhenovia Pharma
Rhenovia Pharma specializes in health and wellness solutions, focusing on fasciatherapy and organic silica supplements. Founded in 2007, the company is headquartered in Mulhouse, France.Rhenovia specializes in innovative health and wellness solutions that encompass a range of therapeutic techniques and complementary products. Central to their offerings is fasciatherapy, a gentle method aimed at targeting the fascia, the connective tissues surrounding muscles and organs. This therapy is designed to alleviate various bodily dysfunctions and enhance overall mental well-being. Additionally, Rhenovia provides organic silica supplements known for their numerous health benefits, particularly for joint health, skin, hair, and nails. The company’s offerings also extend to holistic practices such as couple therapy and support for various health concerns including hair loss and cosmetic procedures, like permanent hair removal.Rhenovia generates revenue through a combination of direct-to-consumer sales and professional partnerships, particularly within the health and wellness sectors. The company’s revenue model typically involves clients purchasing individual sessions of fasciatherapy or subscribing to a series of treatments, allowing for a structured approach to wellness. Additionally, their organic silica products are sold through both retail outlets and online platforms, catering to health-conscious consumers. The pricing structure is tailored to accommodate various client needs, with options available for both single sessions and bundled service packages.Rhenovia Pharma's future growth strategy includes launching new products designed to enhance their therapeutic offerings, although specific release dates are not provided. The company aims to expand its market presence into new geographic regions, specifically targeting urban centers in Europe and North America by 2025.
Who invested in Rhenovia Pharma
2 investors across 1 round
See all investors in Rhenovia Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jun 9, 2010
Amount
$0.4M
Investors
Questions about Rhenovia Pharma
Who invested in Rhenovia Pharma?
Rhenovia Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rhenovia Pharma raised?
Rhenovia Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rhenovia Pharma last raise money?
Rhenovia Pharma's most recent round on record is a Series C, in Jun 2010.
What does Rhenovia Pharma do?
Rhenovia Pharma specializes in health and wellness solutions, focusing on fasciatherapy and organic silica supplements.
Where is Rhenovia Pharma headquartered?
Rhenovia Pharma is headquartered in Mulhouse, France.
Which VCs invest in companies like Rhenovia Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Rhenovia Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Rhenovia Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.